Bazinet, Alexandre http://orcid.org/0000-0001-5538-4943
Bravo, Guillermo Montalban
Article History
Accepted: 13 February 2022
First Online: 23 March 2022
Compliance with Ethical Standards
:
: Alexandre Bazinet declares he has no conflict of interest. Guillermo Montalban-Bravo declares grants or contracts from IFM Therapeutics, Rigel Pharmaceuticals, Jazz Pharmaceuticals, Daichii Sankyo, Stemline Therapeutics, and Salarius Pharmaceuticals.
: The authors did not perform any studies with human or animal subjects as part of this article.